134 related articles for article (PubMed ID: 794584)
1. Specific cytotoxic antibody in the sera of patients with melanoma.
Kilpatrick RJ; Seigler HF
J Surg Res; 1976 Nov; 21(5):301-5. PubMed ID: 794584
[No Abstract] [Full Text] [Related]
2. Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients.
Minden P; Jarrett C; McClatchy JK; Gutterman JU; Hersh EM
Nature; 1976 Oct; 263(5580):774-7. PubMed ID: 792712
[No Abstract] [Full Text] [Related]
3. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
4. BCG immunotherapy of a mucous membrane malignant melanoma. Report of a case.
Pliskin ME; Mastrangelo MJ; Bellet R; Berkelhammer J
Oral Surg Oral Med Oral Pathol; 1976 Jul; 42(1):73-9. PubMed ID: 781579
[No Abstract] [Full Text] [Related]
5. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
Boyle MD; Ohanian SH; Borsos T
J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma.
Spitler LE
J Invest Dermatol; 1976 Sep; 67(3):435-41. PubMed ID: 787436
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma: specific immunity induced by bacillus Calmette-Guérin in BALB-c mice.
Faraci RP; Schour L
Science; 1974 Jul; 185(4145):68-9. PubMed ID: 4599426
[TBL] [Abstract][Full Text] [Related]
8. [Development in the immunotherapy of malignant melanoma].
Tritsch H
Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
10. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
Wile AG; Sparks FC; Morton DL
Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
[TBL] [Abstract][Full Text] [Related]
11. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
12. [Immunotherapy].
Lejeune FJ; Bernheim JL; Vanwijck R
Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
[No Abstract] [Full Text] [Related]
13. In vitro monitoring of cellular function during BCG immunotherapy.
Golub SH; Roth JA; Forsythe A; Morton DL
Bibl Haematol; 1975 Oct; (43):270-3. PubMed ID: 786261
[No Abstract] [Full Text] [Related]
14. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
[TBL] [Abstract][Full Text] [Related]
15. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
Peter HH; Deutschmann EM; Schultheis W; Deicher H
Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
[TBL] [Abstract][Full Text] [Related]
16. Non-specific and specific immunotherapy in patients with melanoma.
Seigler HF; Shingleton WW; Metzgar RS; Buckley CE; Bergoc PM; Miller DS; Fetter BF; Phaup MB
Surgery; 1972 Jul; 72(1):162-74. PubMed ID: 4555924
[No Abstract] [Full Text] [Related]
17. Immunology and the melanomas.
Lewis MG
Curr Top Microbiol Immunol; 1974; 63():49-84. PubMed ID: 4597749
[No Abstract] [Full Text] [Related]
18. Immunological studies on malignant melanomas of man.
Romsdahl MM; Cox IS
Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
[No Abstract] [Full Text] [Related]
19. [Immunologic reactions in malignant melanoma of the skin in man].
Veresova OV; Korosteleva TA
Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
[No Abstract] [Full Text] [Related]
20. Successful transurethral intralesional BCG therapy of a bladder melanoma.
deKernion JB; Golub SH; Gupta RK; Silverstein M; Morton DL
Cancer; 1975 Nov; 36(5):1662-7. PubMed ID: 1192356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]